Search results
Results from the WOW.Com Content Network
Chronic lymphocytic leukemia (CLL) is a type of cancer that affects the blood and bone marrow. [8] [9] In CLL, the bone marrow makes too many lymphocytes, which are a type of white blood cell. [8] [9] In patients with CLL, B cell lymphocytes can begin to collect in their blood, spleen, lymph nodes, and bone marrow.
B-cell chronic lymphocytic leukemia (ICD-O: 9823/3) 30% of all leukemias. Also 3 to 4% of lymphomas in adults [1] Small resting lymphocytes mixed with variable number of large activated cells. Lymph nodes are diffusely effaced [1] CD5, surface immunoglobulin [1] Occurs in older adults. Usually involves lymph nodes, bone marrow and spleen.
The lymphocyte subtypes are B-cells that share certain features with the abnormal clones of lymphocytes that circulate in chronic lymphocytic leukemia/small lymphocyte lymphoma (CLL/SLL) or, less frequently, other types of B-cell malignancies. Some individuals with these circulating B-cells develop CLL/SLL or the lymphoma types indicated by ...
M9823/3 B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (see also M9670/3) Chronic lymphocytic leukemia, B-cell type (includes all variants of BCLL) Chronic lymphocytic leukemia; Chronic lymphoid leukemia; Chronic lymphatic leukemia; M9826/3 Burkitt cell Leukemia (see also M9687/3) Acute lymphoblastic leukemia, mature B-cell type
Lymphoproliferative disorders are a set of disorders characterized by the abnormal proliferation of lymphocytes into a monoclonal lymphocytosis.The two major types of lymphocytes are B cells and T cells, which are derived from pluripotent hematopoietic stem cells in the bone marrow.
Treatment options include watchful waiting, radiation aimed directly at the affected lymph nodes, chemotherapy, and immunotherapy. For patients whose disease becomes more aggressive, autologous stem cell transplantation may be used. [citation needed] There is no consensus on the optimal first-line treatment for follicular lymphoma.
Venetoclax is also indicated as part of a combination therapy for acute myeloid leukemia (AML). [7] For this purpose it is used with azacitidine, decitabine, or low-dose cytarabine for newly diagnosed adults who are age 75 years or older, or those with other health problems where intensive chemotherapy cannot be used.
Large granular lymphocytic (LGL) leukemia is a chronic lymphoproliferative disorder that exhibits an unexplained, chronic (> 6 months) elevation in large granular lymphocytes (LGLs) in the peripheral blood. [1] It is divided in two main categories: T-cell LGL leukemia (T-LGLL) and natural-killer (NK)-cell LGL leukemia (NK-LGLL).